StarGlory Holdings Company Limited (HKG:8213)

Elevation Oncology Ratios and Metrics

Market cap in millions HKD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	178	247	297	193	203	196
Market Cap Growth	-16.79%	-16.79%	54.05%	-5.13%	3.72%	4.44%
Enterprise Value	292	381	421	314	315	290
Last Close Price	0.32	0.45	0.57	0.37	0.39	0.38
PE Ratio	-	-	-	-	-	77.67
PS Ratio	4.75	6.60	2.99	1.19	1.18	1.04
PB Ratio	-1.36	-1.89	-2.23	-1.62	-1.91	-2.31
P/FCF Ratio	112.77	156.83	26.31	16.49	32.10	7.66
P/OCF Ratio	111.85	155.54	25.14	14.51	19.40	6.46
EV/Sales Ratio	7.81	10.19	4.24	1.93	1.83	1.54
EV/FCF Ratio	185.60	241.98	37.31	26.86	49.72	11.33
Debt / Equity Ratio	-1.06	-1.06	-1.17	-1.40	-1.79	-2.15
Debt / EBITDA Ratio	-	-	-	17.45	16.14	9.72
Debt / FCF Ratio	88.31	88.31	13.84	14.22	30.09	7.13
Asset Turnover	0.74	0.74	1.56	1.73	1.40	1.33
Inventory Turnover	142.83	142.83	176.58	64.18	21.03	21.14
Quick Ratio	0.19	0.19	0.13	0.24	0.38	0.39
Current Ratio	0.24	0.24	0.20	0.34	0.47	0.48
Return on Assets (ROA)	-17.60%	-17.60%	-11.44%	-11.06%	-7.70%	-3.64%
Return on Capital (ROIC)	-56.69%	-56.69%	-20.70%	-15.82%	-10.39%	-4.83%
Earnings Yield	-12.54%	-9.02%	-5.46%	-6.43%	-9.75%	1.29%
FCF Yield	0.89%	0.64%	3.80%	6.06%	3.12%	13.06%
Buyback Yield / Dilution	-1.41%	-1.41%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.